Inhibrx, Inc. (INBX) Misses Q2 EPS by 30c
Tweet
Share
E-mailGet Alerts INBX Hot Sheet
Join SI Premium – FREE
Inhibrx, Inc. (NASDAQ: INBX) reported Q2 EPS of ($1.85), $0.30 worse than the analyst estimate of ($1.55). Revenue for the quarter came in at $1.3 million.
For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
- DZ Bank Starts SpaceX (SPCX) at Sell
- TD Cowen Starts Lakefront Biotherapeutics (LKFT) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
